Stryker announces Allan Golston will retire from Board of Directors
10 Fevereiro 2025 - 6:05PM
Stryker (NYSE:SYK) announced today that after 14 years of
distinguished service, Allan Golston has notified the company
that he will not stand for re-election at Stryker's 2025 Annual
Meeting of Shareholders, which is expected to be held on May
8, 2025. Golston joined Stryker’s Board of Directors in 2011
and served as independent Lead Director from 2016 to 2022. He also
served on the Governance and Nominating Committee and as Chair of
the Compensation and Human Capital and Audit Committees. “We are
grateful for Allan’s many contributions to the board over the years
and thank him for his strategic guidance and steadfast support of
our growth ambitions,” said Kevin Lobo, Chair and Chief Executive
Officer, Stryker. “We thank Allan for his leadership and dedication
in helping Stryker advance our mission of making healthcare
better.” Golston has served as the President, United States Program
for the Bill & Melinda Gates Foundation since 2006, and as
Chief Financial and Administrative Officer of the Bill &
Melinda Gates Foundation from 2000 to 2006. He is also a director
of Harley-Davidson, Inc., a manufacturer of motorcycles and
accessories. Golston has extensive experience in auditing, finance
and the healthcare industry. He is a certified public accountant
and has held hospital finance executive positions. In his service
to the Gates Foundation, he has contributed to the strategic
formation and operation of successful initiatives to provide
healthcare, education and other human needs, all of which gave him
an understanding that assisted Stryker in its global efforts to
meet the needs of patients and caregivers.
About Stryker
Stryker is a global leader in medical technologies and, together
with our customers, we are driven to make healthcare better. We
offer innovative products and services in MedSurg, Neurotechnology
and Orthopaedics that help improve patient and healthcare outcomes.
Alongside our customers around the world, we impact more than 150
million patients annually. More information is available at
www.stryker.com.
Contacts
For investor inquiries please contact:Jason Beach, Vice
President, Finance and Investor Relations at 269-385-2600 or
jason.beach@stryker.com
For media inquiries please contact:Yin Becker, Vice
President, Chief Corporate Affairs Officer at 269-385-2600 or
yin.becker@stryker.com
Stryker (NYSE:SYK)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Stryker (NYSE:SYK)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025